Funder
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference66 articles.
1. Lauzardo M, Peloquin CA. Tuberculosis therapy for 2016 and beyond. Exp Opin Pharm. 2016;17:1859–72.
2. Siricilla S, Mitachi K, Wan B, Franzblau SG, Kurosu M. Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors. J Antibiot. 2015;68:271–8.
3. Keri RS, Sasidhar BS, Nagaraja BM, Santos AM. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. Eur J Med Chem. 2015;100:257–69.
4. Muniyan R, Gurunathan J. Antimycobacterial activity of potential plant metabolites with emphasis on management of drug resistant Mycobacterium tuberculosis strains. Res J Biotech. 2017;12:75–86.
5. Liu J, Ren HP. Tuberculosis: current treatment and new drug development. Anti-Infect Agents Med Chem. 2006;5:331–44.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献